Modern diagnostics in acute leukemias
- 1 November 2005
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 56 (2) , 223-234
- https://doi.org/10.1016/j.critrevonc.2004.04.008
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003
- Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatmentLeukemia, 2003
- Correlation of protein expression and gene expression in acute leukemiaCytometry Part B: Clinical Cytometry, 2003
- In Reply:Journal of Clinical Oncology, 2003
- Morphologic Dysplasia in Acute Myeloid Leukemia: Importance of Granulocytic DysplasiaJournal of Clinical Oncology, 2003
- Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspectsLeukemia, 2003
- Rapid diagnostic approach to PML-RARα-positive acute promyelocytic leukemiaThe Hematology Journal, 2002
- Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: A detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24‐color FISHGenes, Chromosomes and Cancer, 2002
- Leukaemia‐associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcomeBritish Journal of Haematology, 1999
- Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhoodThe Lancet, 1998